SEC Charges Theranos, Holmes, and Balwani with Massive Fraud

The US Securities and Exchange Commission charged Theranos, Elizabeth Holmes, and Ramesh Balwani with massive fraud. The charges alleged that Theranos raised over $700 million from investors through years of false statements regarding its technology and financial performance. Theranos and Elizabeth Holmes agreed to settle the charges, with Holmes agreeing to pay a $500,000 penalty, return millions of Theranos shares, and be barred from serving as an executive at a publicly traded company for 10 years.

The regulatory action confirms that Theranos engaged in elaborate fraud to secure investor funding. The settlement terms, which include stripping Elizabeth Holmes of control and imposing career restrictions, severely impact the company's viability and the financial standing of the principals involved.